Clinical Trials
2
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)CC100: Phase 1 Multiple-Dose Safety and Tolerability in Subjects With ALS
- First Posted Date
- 2017-02-09
- Last Posted Date
- 2017-08-03
- Lead Sponsor
- Chemigen, LLC
- Target Recruit Count
- 21
- Registration Number
- NCT03049046
- Locations
- 🇺🇸
Indiana University, IU Health Physicians Neurology, Indianapolis, Indiana, United States
CC100: Safety and Tolerability of Single Doses
- First Posted Date
- 2014-01-30
- Last Posted Date
- 2015-04-30
- Lead Sponsor
- Chemigen, LLC
- Target Recruit Count
- 18
- Registration Number
- NCT02050334
- Locations
- 🇺🇸
IU Health Neuroscience Center, Indianapolis, Indiana, United States
News
No news found